Clinical trial · Observational
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
NCT05871164CI-TRIAL-00106968RAFPAN2recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Tumor | Pancreatic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pancreatic radiofrequency | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patient to be treated for a tumor of the pancreas
- description
- Patient to be treated for a tumor of the pancreas by ultrasound-guided radiofrequency with a fine needle, with Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting
- interventionNames
- Procedure: Pancreatic radiofrequency
Primary outcomes (1)
- measure
- Carcinological efficacy of pancreatic radiofrequency
- timeFrame
- 5 years
- description
- The primary endpoint of the study is the oncological efficacy of pancreatic radiofrequency, which will be assessed by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after treatment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years old; * Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle; * Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting; * Patient able to understand the information related to the study; * Patient accepting study follow-up visits; * Patient having been informed and agreeing to participate in the study. Exclusion Criteria: * Patient with a contraindication to radiofrequency treatment; * Pregnant or breastfeeding women
References
Publications (0)
Data not yet available
No reference posted for this study.